Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RF (radiofrequency) ablation and among latest NICE (UK National Institute for Clinical Excellence) approvals:

This article was originally published in Clinica

Executive Summary

The National Institute for Clinical Excellence (NICE) has published its verdict on the safety and efficacy of five new interventional procedures. Three of these were deemed to have sufficient evidence to support their use in the National Health Service. These are coblation tonsillectomy, percutaneous vertebroplasty and radiofrequency ablation of varicose veins. The uncertainty surrounding the other two - stent-graft placement in abdominal aortic aneurysms and stereotactic radiosurgery for trigeminal neuralgia using a gamma knife - means that clinicians wishing to provide these will need to perform them under the strictest approval, consent, and clinical audit conditions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063780

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel